Nitric Oxide Administration Restores the Hepatic Artery Buffer Response During Porcine Endotoxemia

REFERENCES

• Halvorsen L, Roth R, Gunther R A, et al. Liver hemodynamics during portal venous endotoxemia in swine. Circ Shock. 1993; 41: 166–175
   PubMedGoogle Scholar
• Lautt W W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol. 1985; 249: G549–556
   PubMed Web of Science ®Google Scholar
• Ayuse T, Brienza N, Revelly J P, et al. Alternations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol. 1995a; 268: H1106–1114
   Google Scholar
• Mathie R T, Ralevic V, Alexander B, et al. Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. Br J Pharmacol. 1991; 103: 1602–1606
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer R M, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993; 329: 2002–2012
   PubMed Web of Science ®Google Scholar
• Ayuse T, Brienza N, Revelly J P, et al. Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol. 1995b; 78: 1319–1329
   PubMed Web of Science ®Google Scholar
• Saetre T, Gundersen Y, Smiseth O A, et al. Hepatic oxygen metabolism in porcine endotoxemia: the effect of nitric oxide synthase inhibition. Am J Physiol. 1998; 275: G1377–1385
   Google Scholar
• Offner P J, Robertson F M, Pruitt B A, Jr. Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock. J Trauma. 1995; 39: 338–343
   PubMedGoogle Scholar
• Robertson F M, Offner P J, Ciceri D P, et al. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg. 1994; 129: 149–155, discussion 155–146
   PubMedGoogle Scholar
• Harbrecht B G, Billiar T R, Stadler J, et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med. 1992; 20: 1568–1574
   PubMed Web of Science ®Google Scholar
• Pastor C M, Losser M R, Payen D. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology. 1995; 22: 1547–1553
   PubMed Web of Science ®Google Scholar
• Gundersen Y, Corso C O, Leiderer R, et al. Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: effects on hepatic morphology and function. Shock. 1997; 8: 368–372
   PubMed Web of Science ®Google Scholar
• Gundersen Y, Corso C O, Leiderer R, et al. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med. 1998; 24: 1257–1263
   PubMed Web of Science ®Google Scholar
• Yoshizumi M, Perrella M A, Burnett J C, Jr., et al. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993; 73: 205–209
   PubMed Web of Science ®Google Scholar
• Parker J L, Adams H R. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res. 1993; 72: 539–551
   PubMed Web of Science ®Google Scholar
• Lautt W W, Greenway C V. Conceptual review of the hepatic vascular bed. Hepatology. 1987; 7: 952–963
   PubMed Web of Science ®Google Scholar
• Richter S, Olinger A, Hildebrandt U, et al. Loss of physiologic hepatic blood flow control (“hepatic arterial buffer response”) during CO2-pneumoperitoneum in the rat. Anesth Analg. 2001; 93: 872–877
   PubMed Web of Science ®Google Scholar
• Jakob S M, Tenhunen J J, Laitinen S, et al. Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol Gastrointest Liver Physiol. 2001; 280: G819–827
   Web of Science ®Google Scholar
• Iwao T, Toyonaga A, Shigemori H, et al. Hepatic artery hemodynamic responsiveness to altered portal blood flow in normal and cirrhotic livers. Radiology. 1996; 200: 793–798
   PubMed Web of Science ®Google Scholar
• Gulberg V, Haag K, Rossle M, et al. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology. 2002; 35: 630–634
   PubMed Web of Science ®Google Scholar
• Aoki T, Imamura H, Kaneko J, et al. Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis. Liver Transpl. 2005; 11: 684–691
   PubMed Web of Science ®Google Scholar
• Zipprich A, Steudel N, Behrmann C, et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology. 2003; 37: 385–392
   PubMed Web of Science ®Google Scholar
• Cardoso J E, Gautreau C, Jeyaraj P R, et al. Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology. 1994; 19: 375–380
   PubMed Web of Science ®Google Scholar
• Asfar P, Hauser B, Ivanyi Z, et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med. 2005; 33: 373–380
   PubMed Web of Science ®Google Scholar
• Cantoni L, Di Nicolantonio F, Barelli D, et al. Modulation of cerebellar and hepatic nitric oxide synthase by exogenous arginine and endotoxin. Nitric Oxide. 2001; 5: 198–207
   PubMed Web of Science ®Google Scholar
• Dahm P L, Thorne J, Myhre E, et al. Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition. Acta Anaesthesiol Scand. 1999; 43: 56–63
   PubMed Web of Science ®Google Scholar
• Wray G M, Millar C G, Hinds C J, et al. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock. 1998; 9: 329–335
   PubMed Web of Science ®Google Scholar
• Kengatharan K M, De Kimpe S J, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol. 1996; 119: 1411–1421
   PubMed Web of Science ®Google Scholar
• Billiar T R. Nitric oxide. Novel biology with clinical relevance. Ann Surg. 1995; 221: 339–349
   PubMed Web of Science ®Google Scholar
• Klemm K, Moody F G. Regional intestinal blood flow and nitric oxide synthase inhibition during sepsis in the rat. Ann Surg. 1998; 227: 126–133
   PubMed Web of Science ®Google Scholar
• Nava E, Salazar F J. Comparative effects of nitric oxide synthesis inhibition and catecholamine treatment in a rat model of endotoxin shock. Eur J Clin Invest. 1997; 27: 673–679
   PubMed Web of Science ®Google Scholar
• Ebisawa Y, Kono T, Yoneda M, et al. Direct evidence that induced nitric oxide production in hepatocytes prevents liver damage during lipopolysaccharide tolerance in rats. J Surg Res. 2004; 118: 183–189
   PubMed Web of Science ®Google Scholar
• Brown K M, Brems J J, Moazzam F N, et al. The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia. J Am Coll Surg. 2003; 197: 261–269
   PubMed Web of Science ®Google Scholar
• Pastor C M, Suter P M. Hepatic hemodynamics and cell functions in human and experimental sepsis. Anesth Analg. 1999; 89: 344–352
   PubMed Web of Science ®Google Scholar
• Lautt W W, Legare D J, d'Almeida M S. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol. 1985; 248: H331–338
   PubMed Web of Science ®Google Scholar
• Lu J L, Schmiege L M, 3rd, Kuo L, et al. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun. 1996; 225: 1–5
   PubMed Web of Science ®Google Scholar
• Liu S F, Adcock I M, Old R W, et al. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med. 1996; 24: 1219–1225
   PubMed Web of Science ®Google Scholar
• Liu T H, Robinson E K, Helmer K S, et al. Does upregulation of inducible nitric oxide synthase play a role in hepatic injury?. Shock. 2002; 18: 549–554
   PubMed Web of Science ®Google Scholar
• Joyce M, Casey R, Gang C, et al. Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses. Br J Surg. 2005
   PubMed Web of Science ®Google Scholar
• Vo P A, Lad B, Tomlinson J A, et al. Autoregulatory role of endothelium-derived nitric oxide (NO) on Lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem. 2005; 280: 7236–7243
   PubMed Web of Science ®Google Scholar
• Wang W W, Smith D LH, Zucker S D. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology. 2004; 40: 424–433
   PubMed Web of Science ®Google Scholar